Methylphenidate extended-release capsules: A new formulation for attention-deficit hyperactivity disorder

Frontiers in Drug Design and Discovery

Volumn 4, Issue 1, 2009, Pages 228-246

  García García, Pilar ^a   López Muñoz, Francisco ^a   Molina, Juan D ^b   Fischer, Roland ^c   Alamo, Cecilio ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b Hospital Dr Rodríguez Lafora   (Spain)

^c Medice chem phar   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84855911086     PISSN: 15740889     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (86)

1. Fischman, A.J.; Madras, B.K. Biol. Psychiatry, 2005, 57, 1374-1376.
2. Biederman, J. Biol. Psychiatry, 2005, 57, 1215-1220.
3. Polanczyk, G.; Silva, M.; Lessa, B.; Biedermanm, J.; Rodhe, L.A. Am. J. Psychiatry, 2007, 164, 942-948.
4. López-Muñoz, F.; Alamo, C.; Quintero-Gutiérrez, F.J.; García-García, P. Eur. Child Adolesc. Psychiatry, 2008, in press.
5. Faraone, S.V.; Sergean, J.A.; Gillberg, C.; Biederman, J. World Psychiatry, 2003, 2, 104-113.
6. Kessler, R.C. Prevalence of ADHD in the US: Results from the NCS-R, American Psychiatric Association: Washington DC, 2004.
7. Kessler, R.C.; Berglund, P.; Demler, O.; Jin, R.; Merikangas, K.R.; Walters, E.E. Arch. Gen. Psychiatry, 2005, 62, 593-602.
8. Spencer, T.J.; Biederman, J.; Mick, E. J. Pediatr. Psychol., 2007, 32, 631-642.
9. Kolar, D.; Keller, A.; Golfinopoulos, M.; Cumyn, L.; Syer, C.; Hechtman, L. Neuropsychiatr. Dis. Treat., 2008, 4, 107-121.
10. Patrick, K.S.; González, M.A.; Straughn, A.B.; Markowitz, J.S. Exp. Opin. Drug Deliv., 2005, 2, 121-143.
11. Popper, C.; West, S. In DSM-IV: Tratado de psiquiatría, 3rd ed.; Hales, R.E.; Yudofsky, S.C.; Talbott, J.A. Eds.; Masson: Barcelona, 2000, pp. 825-856.
12. Valdizan, J.R. Consenso multidisciplinar en TDAH: infancia, adolescencia y adultos, 2005. Available at: http://www.aapi.org.ar/Aapi/ArchivosTDAH/TDAH%20%20documento%20presentado%20en%20M as%20Casadevall.pdf.
13. Rappley, M. New Engl. J. Med., 2005, 352, 165-173.
14. Conners, C.K. J. Attent. Disord., 2002, 6, S17-S30.
15. Faraone, S.V.; Spencer, T.; Aleardi, M.; Pagano, C.; Biederman, J.J. Clin. Psychopharmacol., 2004, 24, 24-28.
16. Barkley, R.A. In Attention-Deficit Hyperactivity Disorder. A Handbook for Diagnosis and Treatment, 3rd ed.; Barkley, R.A. Ed.; Guilford Press: New York, 2006, pp. 3-75.
17. MTA Cooperative Group. Arch. Gen. Psychiatry, 1999, 56, 1073-1086.
18. Taylor, E.; Döpfner, M.; Sergeant, J.; Asherson, P.; Banaschewski, T.; Buitelaar, J.; Coghill, D.; Danckaerts, M.; Rothenberger, A; Sonuga-Barke, E.; Steinhausen, H.C.; Zuddas, A. Eur. Child Adolesc. Psychiatry, 2004, 13, S7-S30.
19. Banaschewski, T.; Coghill, D.; Santosh, P.; Zuddas, A.; Asherson, P.; Buitelaar, J.; Danckaerts, M.; Döpfner, M.; Faraone, S.V.; Rothenberger, A.; Sergeant, J.; Steinhausen, H.C.; Sonuga-Barke, E.J.S.; Taylor, E. Eur. Child Adolesc. Psychiatry, 2006, 15, 476-495.
20. Connor, D.F.; Steingard, R.J. CNS Drug, 2004, 18, 1001-1030.
21. Madaan, V.; Kinnan, S.; Daughtonm J.; Kratochvilm C.J. Exp. Rev. Neurother., 2006, 6, 1375-1385.
22. Biederman, J. J. Clin. Psychiatry, 2006, 67, S3-S6.
23. Keith, S. Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 2006, 30, 996-1008.
24. Prince, J.B. Child Adolesc. Psychiatry Clin. North Am., 2006, 15, 13-50.
25. Quintero-Gutiérrez, F.J.; Correas, J.; Quintero-Lumbreras, F.J. Déficit de atención e hiperactividad a lo largo de la vida, Editorial Ergon: Madrid, 2006.
26. Eisenberg, L.J. Child Adolesc. Psychopharmacol., 2007, 17, 279-283.
27. World Health Organization. The international classification of diseases, 10th ed., World Health Organization: Geneva, 1993.
28. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed., American Psychiatric Association: Washington DC, 1994.
29. Greenhill, L.L. Psychiatr. Ann., 1989, 19, 604-613.
30. Swanson, J.M.; Sergant, J.A.; Taylor, E.; Sonuga-Barke, E.J.S.; Jensen, P.S.; Cantwell, D.P. Lancet, 1998, 351, 429-433.
31. Lee, S.I.; Schachar, R.J.; Chen, S.X.; Ornstein, T.J.; Charach, A.; Barr, C.; Ickowicz, A. J. Child. Psychol. Psychiatr., 2008, 49, 70-78.
32. Sandberg, S. Br. J. Psychiatry, 1996, 169, 10-17.
33. Garitty, C.M. Can. Pharm. J., 1996, 129, 36-42.
34. Cosgrove, P.V.F. Prim. Care Psychiatry, 1997, 3, 101-113.
35. Jaideep, T.; Reddy, Y.C.J.; Srinath, S. Bipolar Dis., 2006, 8, 182-187.
36. Cumyn, L.; Kolar, D.; Keller, A.; Hechtman, L. Exp. Rev. Neurother., 2007, 7, 1375-1390.
37. Biederman, J. J. Clin. Psychiatry, 1998, 59, 4-16.
38. Safer, D.J. CNS Drugs, 1997, 7, 264-272.
39. Ballard, S.; Bolan, M.; Burton, M.; Snyder, S.; Pasterczyk-Seabolt, C.; Martin, D. Adolescence, 1997, 32, 855-862.
40. Kieling, C.; Goncalves, R.R.F.; Tannock, R.; Castellanos, F.X. Child Adolesc. Psychiatr. Clin. North Am., 2008, 17, 285-307.
41. Mick, E.; Faraone, S.V. Child Adolesc. Psychiatr. Clin. North Am., 2008, 17, 261-284.
42. Arnsten, A.F. J. Clin. Psychiatry, 2006, 67(Suppl 8), S7-S12.
43. Fassbender, C.; Schweitzer, J.B. Clin. Psychol. Rev., 2006, 26, 445-465.
44. Biederman, J.; Spencer, T.J. Child Adolesc. Psychiatr. Clin. North Am., 2008, 17, 439-458.
45. Jensen, P.S.; Arnold, L.E. Pediatrics, 2004, 113, 754-761.
46. Smoot, L.C.; Boothby, L.A.; Gillett, R.C. Int. J. Clin. Pract., 2007, 61, 1730-1738.
47. Scottish Intercollegiate Guidelines Network. Attention Deficit and Hyperactivity Disorders in Children and Young People. A National Clinical Guideline, SIGN: Edinburgh, 2001.
48. Wilens, T.; Spencer, T.; Biederman, J.A. J. Attent. Dis., 2002, 5, 189-202.
49. Kutcher, S.; Aman, M.; Brooks, S.J.; Buitelaar, J.; Van Dalen, E.; Fegert, J.; Findling, R.L.; Fisman, S.; Grrennhill, L.L.; Huss, M.; Kusumakar, V.; Pine, D.; Taylor, E.; Tyano, S. Eur. Neuropsychopharmacol., 2004, 14, 11-28.
50. Sonuga-Barke, E.; Van Lier, P.; Swanson, J.; Coghill, D.; Wigal, S.; Vandenberghe, M.; Hatch, S. Eur. Child Adolesc. Psychiatry, 2008, 17, 245-254.
51. Harpin, V.A. Arch. Dis. Child Educ. Pract., 2008, 93, 58-65.
52. Kostrzewa, R.M.; Kostrzewa, J.P.; Kostrzewa, R.A.; Nowak, P.; Brus, R. J. Neural Transm., 2008, 115, 287-298.
53. Challman, T.D.; Lipsky, J.J. Mayo Clin. Proc., 2000, 75, 711-721.
54. Wolraich, M.L.; Doffing, M. CNS Drug, 2004, 18, 243-250.
55. Wigal, S.B.; Gupta, S.; Greenhill, L.; Posner, K.; Lerner, M.; Steinhoff, K.; Wigal, T.; Kapelinski, A.; Martinez, J.; Modi, N.B.; Stehli, A.; Swanson, J. J. Child Adolesc. Psychopharmacol., 2007, 17, 153-164.
56. Tuerck, D.; Appel-Dingemanse, S.; Maboudian, M.; Pommier, F.; Wang, Y.; Sedek, G. J. Clin. Pharmacol., 2007, 47, 64-69.
57. Pelz, R.; Banaschewski, T.; Becker, K. Klin. Padiatr., 2008, 220, 93-100.
58. Liu, F.; Muniz, R.; Minami, H.; Silva, R.R. Psychiatr. Q., 2005, 76, 259-269.
59. Swanson, J.; Kinsbourne, M.; Roberts, W.; Zucker, K. Pediatrics, 1978, 61, 21-29.
60. Holmes, V. Int. J. Psychiatr. Med., 1995, 25, 1-19.
61. Patrick, K.S.; Markowitz, J.S. Hum. Psychopharmacol., 1997, 12, 527-546.
62. Schachter, H.M.; King, J.; Langford, S.; Moher, D. Can. Med. Assoc. J., 2001, 27, 1475-1488.
63. Schulte-Markwort, M.; Warnke, A. Methylphenidat, Thieme: Stuttgart, 2004.
64. Wigal, S.; Swanson, J.M.; Feifel, D.; Sangal, R.B.; Elia, J.; Casat, C.D.; Zeldis, J.B.; Conners, C.K. J. Am. Acad. Child Adolesc. Psychiatry, 2004, 43, 1406-1414.
65. McGough, J.J.; Pataki, C.S.; Suddath, R. Exp. Rev. Neurother., 2005, 5, 437-441.
66. Robinson, D.M.; Keating, G.M. Drugs, 2006, 66, 661-668.
67. Biederman, J.; Quinn, D,; Weiss, M.; Markabi, S.; Weidenman, M.; Edson, K.; Karlsson, G.; Pohlmann, H.; Wigal, S. Paediatr. Drugs, 2003, 5, 833-841.
68. Artigas-Pallares, J. Rev. Neurol., 2004, 38, S117-S123.
69. Anderson, V.R.; Keating G.M. Pediatr. Drugs, 2006, 8, 319-333.
70. Keating, G.M.; McClellan, K.; Jarvis, B. CNS Drugs, 2001, 15, 495-500.
71. Mulas, F.; Téllez de Meneses, M.; Hernández-Muela, S.; Mattos, L.; Pitarch, I. Rev. Neurol., 2005, 40, S49-S55.
72. Wigal, S.B.; Gupta, S.; Greenhill, L.; Posner, K.; Lerner, M.; Steinhoff, K.; Wigal, T.; Kapelinski, A.; Martinez, J.; Modi, N.B.; Stehli, A.; Swanson, J.; Wilens, T.; McBurnett, K.; Stein, M.; Lerner, M.; Spencer, T.; Wolraich, M. J. Am. Acad. Child Adolesc. Psychiatry, 2005, 44, 1015-1023.
73. Abramowitz, M. Med. Lett., 2005, 48, 49-51.
74. López, F.A. J. Dev. Behav. Pediatr., 2006, 27, 410-416.
75. Anderson, V.R.; Scott, L.J. Drugs, 2006, 66, 1117-1126.
76. Wilens, T.E.; Boellner, S.W.; López, F.A.; Turnbow, J.M.; Wigal, S.B; Childress, A.C.; Abikoff, H.B.; Manos, M.J. J. Am. Acad. Child Adolesc. Psychiatry, 2008, 47, 700-708.
77. Anonymous. Med. Lett., 2001, 43, 83-84.
78. Döpfner, M.; Gerber, W.D.; Banaschewski, T.; Breuer, D.; Freisleder, F.J.; Gerber-von Müller, G.; Günter, M.; Hässler, F.; Ose, C.; Rothenberger, A.; Schmeck, K.; Sinzig, J.; Stadler, C.; Uebel, H.; Lehmkuhl, G. Eur. Child Adolesc. Psychiatry, 2004, 13, 93-101.
79. Fischer, R.; Schütz, H.; Grossman, M.; Leis, H.J.; Armmer R. Int. J. Clin. Pharmacol. Ther., 2006, 44, 135-141.
80. Lerner, M.; Wigal, T. Pediatr. Ann., 2008, 37, 37-45.
81. SPC Medikinet. MEDICE Arzneimittel Pütter GmbH & Co. KG, Fach information: Berlin, 2005.
82. Ghuman, J.K.; Cataldo, M.D.; Beck, M.H.; Slifer, K.J. J. Child. Adolesc. Psychopharmacol., 2005, 14, 601-611.
83. Beck, M.H.; Cataldo, M.; Slifer, K.J.; Pulbrook, V.; Guhman, J.K. Clin. Pediatr., 2005, 44, 515-526.
84. Döpfner, M.; Banaschewski, T.; Schmidt, J.; Uebel, H.; Schmeck, K.; Gerber, W.D.; Günter, M.; Knölker, U.; Gehrke, M.; Häbler, F.; Möhler, E.; Brünger, M.; Ose, C.; Fischer, R.; Poustka, F.; Lehmkuhl, G.; Rothenberger, A. Nervenheilkunde, 2003, 22, 85-92.
85. Sinzig, J.K.; Döpfner, M.; Pück, J.; Banaschewski, T.; Stephani, U.; Lehmkuhl, G.; Rothenberger, A.; Arbeitsgruppe methylphenidat. Z. Kinder-Jugendpsychiatr., 2004, 32, 225-233.
86. Sinzig, J.K.; Döpfner, M.; Lehmkuhl, G.; German Methylphenidate Study Group. J. Child Adolesc. Psychopharmacol., 2007, 17, 628-632.